Clinical Trial Update: Retrospective Study on the Safety of Nivolumab in Patients With mRCC and Renal Failure

View source ↗

Summary

This clinical trial update provides a retrospective assessment of the safety of nivolumab in patients with metastatic renal cell carcinoma and renal impairment;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Azienda USL Reggio Emilia - IRCCS | Conditions: Metastatic Renal Cell Carcinoma | Status: TERMINATED